Healthcare entity
regulation is the sole category represented across all 1 tracked stories. National Centre for Pharmacoeconomics (NCPE) is most often covered alongside Biogen, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention National Centre for Pharmacoeconomics (NCPE), all published on August 3, 2026.
Last mentioned: Aug 3, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. National Centre for Pharmacoeconomics (NCPE) is most often covered alongside Biogen, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention National Centre for Pharmacoeconomics (NCPE), all published on August 3, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering National Centre for Pharmacoeconomics (NCPE). Shared-story counts are live from our verified record — not editorial picks.
A woman with Friedreich’s ataxia sues the HSE over an unacceptably prolonged reimbursement decision for omaveloxolone, a treatment that could slow her decline and that is already standard care in 12 other European countries.
Source: roscommonherald.ie · laois-nationalist.ie
National Centre for Pharmacoeconomics (NCPE) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
